Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Ryanodex earns FDA fast track designation for exertional heat stroke

Feb. 2, 2016

Tenax updates status of ongoing phase III trial of levosimendan in cardiac surgery

Feb. 2, 2016

EMA committee backs approval of Uptravi for PAH

Feb. 1, 2016

New animal model designed to reproduce ischemia in head and neck surgery

Jan. 26, 2016

FDA grants orphan drug designation to gene therapy for critical limb ischemia

Jan. 15, 2016

Tracleer dispersible tablets launched for pediatric use in Japan

Jan. 13, 2016

MedImmune initiates phase II trial of MEDI-6012 in coronary artery disease

Jan. 5, 2016

Merck & Co. develops sGC activators

Dec. 24, 2015

FDA approves Uptravi for pulmonary arterial hypertension

Dec. 22, 2015

Oslo Universitetssykehus divulges SERCA2-PDE3A interaction inhibitors

Dec. 22, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.